• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

60岁及以上受者单肺移植与双肺移植后的结果。

Outcome following single vs bilateral lung transplantation in recipients 60 years of age and older.

作者信息

Fischer S, Meyer K, Tessmann R, Meyer A, Gohrbandt B, Simon A, Hagl C, Kallenbach K, Haverich A, Strüber M

机构信息

Hannover Thoracic Organ Transplant Program, Division of Thoracic and Cardiovascular Surgery Hannover Medical School, Hannover, Germany.

出版信息

Transplant Proc. 2005 Mar;37(2):1369-70. doi: 10.1016/j.transproceed.2004.12.269.

DOI:10.1016/j.transproceed.2004.12.269
PMID:15848723
Abstract

AIMS

The significant shortage of donor organs in lung transplantation necessitates a careful selection of lung transplant recipients. The outcome of lung transplant recipients aged 60 years and older has not been analyzed systematically.

METHODS

We retrospectively reviewed our experience with older recipients. Between January 1999 and July 2003, 248 patients underwent lung transplantation at our institution, of which 18 were aged 60 years and older (7.3%, range 60-66, mean 62 +/- 1.1).

RESULTS

Eleven (61%) of the recipients 60 years and older received a single (SLTx) and seven (39%), a bilateral lung transplant. Donor age in the single transplant cohort was 30 +/- 4 years. It was 33 +/- 3 years in bilateral patients. Posttransplant ventilation time was significantly different among groups, with 282 +/- 32 hours after bilateral and 56 +/- 13 hours after transplant (P < .05). Also significantly longer was the length of the ICU stay in the bilateral group. First PaO2 in the ICU was not different among the two groups. The 1-year survival in the single transplant group was significantly better compared to the bilateral group with 73% versus 43%, respectively.

CONCLUSIONS

The 1-year survival following lung transplantation in patients older than 60 years is markedly reduced compared to recipients under 60 years of age. If a lung transplant is considered in a recipient above the age of 60 years, a single transplant should be favoured. If that is not indicated, patients over 60 should be very carefully selected for bilateral transplant.

摘要

目的

肺移植中供体器官的严重短缺使得必须仔细挑选肺移植受者。60岁及以上肺移植受者的结局尚未得到系统分析。

方法

我们回顾性分析了我们在老年受者方面的经验。1999年1月至2003年7月期间,我们机构有248例患者接受了肺移植,其中18例年龄在60岁及以上(7.3%,范围60 - 66岁,平均62±1.1岁)。

结果

60岁及以上的受者中,11例(61%)接受了单肺移植(SLTx),7例(39%)接受了双肺移植。单肺移植组供体年龄为30±4岁。双肺移植患者为33±3岁。各组术后通气时间差异显著,双肺移植后为282±32小时,单肺移植后为56±13小时(P <.05)。双肺移植组的重症监护病房(ICU)住院时间也显著更长。两组在ICU的首次动脉血氧分压(PaO2)无差异。单肺移植组的1年生存率明显高于双肺移植组,分别为73%和43%。

结论

与60岁以下的受者相比,60岁以上患者肺移植后的1年生存率显著降低。如果考虑为60岁以上的受者进行肺移植,应优先选择单肺移植。如果不适合单肺移植,则对于60岁以上的患者进行双肺移植时应非常谨慎地挑选。

相似文献

1
Outcome following single vs bilateral lung transplantation in recipients 60 years of age and older.60岁及以上受者单肺移植与双肺移植后的结果。
Transplant Proc. 2005 Mar;37(2):1369-70. doi: 10.1016/j.transproceed.2004.12.269.
2
Lung transplantation with lungs from donors fifty years of age and older.使用50岁及以上供体的肺进行肺移植。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):919-25. doi: 10.1016/j.jtcvs.2004.07.053.
3
Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.1997年至1999年在欧洲移植组织进行的所有连续单纯心脏移植和单纯肺移植的三年生存率。
Clin Transpl. 2003:89-100.
4
Impact of bilateral versus single lung transplantation on survival in recipients 60 years of age and older: analysis of United Network for Organ Sharing database.双侧肺移植与单肺移植对60岁及以上受者生存的影响:器官共享联合网络数据库分析
J Thorac Cardiovasc Surg. 2007 Feb;133(2):541-7. doi: 10.1016/j.jtcvs.2006.09.062. Epub 2007 Jan 10.
5
Early outcome after single vs bilateral lung transplantation in older recipients.老年受者单肺移植与双肺移植后的早期结果。
Transplant Proc. 2008 Nov;40(9):3088-9. doi: 10.1016/j.transproceed.2008.08.119.
6
Lung transplantation in older patients?老年患者的肺移植?
J Thorac Cardiovasc Surg. 2008 Feb;135(2):412-20. doi: 10.1016/j.jtcvs.2007.09.030. Epub 2007 Dec 26.
7
Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience.60岁及以上供体对肺移植术后结局的影响:一项11年单中心经验的结果
J Thorac Cardiovasc Surg. 2007 Feb;133(2):525-31. doi: 10.1016/j.jtcvs.2006.09.054. Epub 2006 Dec 29.
8
Expanding the donor pool: lung transplantation with donors 55 years and older.扩大供体库:55岁及以上供体的肺移植
Transplant Proc. 2006 Oct;38(8):2691-3. doi: 10.1016/j.transproceed.2006.07.037.
9
The Eurotransplant Study on Twin Lung Transplants (ESOTWIN): 90 paired single-lung transplants from the same donor.
Transplantation. 2003 Dec 15;76(11):1604-8. doi: 10.1097/01.TP.0000092312.54304.B0.
10
Single-lung transplantation: does side matter?单肺移植:肺叶的位置重要吗?
Eur J Cardiothorac Surg. 2011 Aug;40(2):e83-92. doi: 10.1016/j.ejcts.2011.03.011. Epub 2011 Apr 14.

引用本文的文献

1
Survival outcomes and risk factors after lung transplantation in patients with pre-transplant malignancy: a national cohort study.移植前患有恶性肿瘤的患者肺移植后的生存结果和危险因素:一项全国队列研究。
Transl Lung Cancer Res. 2025 Jul 31;14(7):2598-2610. doi: 10.21037/tlcr-2025-224. Epub 2025 Jul 28.
2
Risk factors for mid- and long-term mortality in lung transplant recipients aged 70 years and older.70岁及以上肺移植受者中长期死亡的危险因素。
Interdiscip Cardiovasc Thorac Surg. 2024 Jul 3;39(1). doi: 10.1093/icvts/ivae117.
3
Lung Transplantation Outcomes in Recipients Aged 70 Years or Older and the Impact of Center Volume.
70岁及以上受者的肺移植结果及中心手术量的影响。
J Clin Med. 2023 Aug 18;12(16):5372. doi: 10.3390/jcm12165372.
4
Characteristics, Trends, and Predictors of Specialty Palliative Care Utilization after Lung Transplantation.肺移植后专科姑息治疗利用的特点、趋势和预测因素。
J Palliat Med. 2019 Sep;22(9):1092-1098. doi: 10.1089/jpm.2018.0560. Epub 2019 Apr 9.
5
Lung transplantation in elderly patients.老年患者的肺移植
J Thorac Dis. 2017 Sep;9(9):3346-3351. doi: 10.21037/jtd.2017.08.31.
6
Lung transplantation: a treatment option in end-stage lung disease.肺移植:终末期肺病的治疗选择。
Dtsch Arztebl Int. 2014 Feb 14;111(7):107-16. doi: 10.3238/arztebl.2014.0107.